Shares of cannabis companies such as Tilray, Inc. TLRY and Canopy Growth Corporation CGC are trading higher after BofA Securities reinstated a Buy rating on the stocks.
BofA Securities analyst Heather Balsky reinstated a Buy rating on Tilray's stock with a $23 price target, while Canopy Growth received a $36 price target.
Tilray cultivates and sells medical and recreational cannabis. The stock was trading up 8.7% at $19.26 at the time of publication. The stock has a 52-week high of $67 and a 52-week low of $4.41.
Canopy Growth cultivates and sells medicinal and recreational cannabis, and hemp. The stock was trading up 4% at $28. The stock has a 52-week high of $56.50 and a 52-week low of $12.95.
See also: How to Buy Tilray Here (ACB) Stock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
